Data show that subchondral pathology was associated with symptomatic knee OA independently of chondropathy and synovitis.
Lutikizumab may not improve pain or inflammation in patients with knee osteoarthritis and concomitant synovitis.
Researchers observed substantial statewide variation in rates of treatment with long-term opioid therapy in osteoarthritis.
The presence of Heberden nodes may be predictive of increased MRI-based periarticular bone area expansion.
Tanezumab is a humanized monoclonal antibody that selectively targets, binds to, and inhibits nerve growth factor (NGF).
Pre-surgical pain catastrophizing may be independently associated with quality of life in patients with severe hip osteoarthritis.
A text-messaging bot is effective for increasing patient engagement after primary total knee or hip arthroplasty.
Data show a causal association between lower LDL cholesterol and increased risk for osteoarthritis.
Investigators suggest a possible link between accelerated knee osteoarthritis and destabilizing meniscal tears in ≥2 areas along with other pathologies.
Radiographic knee osteoarthritis is associated with an increased risk for mortality from cardiovascular disease, diabetes, and renal diseases, but self-reported OA is not.